Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RDGT
RDGT logo

RDGT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.029
Open
0.028
VWAP
0.03
Vol
74.25M
Mkt Cap
508.34K
Low
0.025
Amount
2.04M
EV/EBITDA(TTM)
-4.88
Total Shares
18.29M
EV
-8.68M
EV/OCF(TTM)
-0.52
P/S(TTM)
0.00
Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.
Show More

Events Timeline

(ET)
2025-12-04
16:50:00
Ridgetech Files $200M Mixed Securities Shelf
select

News

PRnewswire
4.5
03-04PRnewswire
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
  • Supply Chain Integration Strategy: Ridgetech plans to enhance its competitiveness in China's pharmaceutical and healthcare market by integrating its wholesale distribution network and B2B platform, which is expected to accelerate the transition from a traffic-driven to a value-driven business model.
  • Digital Innovation Driving Growth: Subsidiary Allright will serve as the core digital engine, aiming to expand its customer base to 300,000 in 2026, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate, further enhancing market influence.
  • Synergistic Dual-Engine Effects: Ridgetech will integrate its offline wholesale platform Jiuxin Medicine with Allright to optimize procurement and sales processes, improving response speed and operational agility, thereby achieving higher turnover efficiency.
  • Management Strategic Outlook: CEO Frank Zhao stated that the company is committed to achieving its 2026 and medium- to long-term strategic objectives through a clear strategic roadmap and an open collaborative framework, driving high-quality development and enhancing market position.
Newsfilter
2.0
03-04Newsfilter
Ridgetech Unveils Dual-Engine Growth Strategy for 2026
  • Supply Chain Integration Strategy: Ridgetech plans to achieve dual breakthroughs in business model innovation and value creation in 2026 by integrating its wholesale distribution network and B2B platform, thereby strengthening its long-term growth foundation in China's pharmaceutical and healthcare supply chain.
  • Core Business Enhancement: The company aims to further enhance the competitiveness of its wholesale business by deepening strategic cooperation with core suppliers and expanding distribution coverage of high-margin brands, which is expected to accelerate its transformation from a traffic-driven to a value-driven business model.
  • Digital Innovation Driving Growth: Ridgetech's wholly-owned subsidiary Allright will serve as the core digital engine, targeting to expand its customer base to 300,000, achieve a 30% year-on-year increase in new B2B customers, and exceed a 30% online business penetration rate in 2026.
  • Synergistic Dual-Engine Effects: Ridgetech plans to systematically introduce Jiuxin Medicine's supply chain products onto the Allright platform, optimizing procurement and sales processes to enhance operational agility, thereby establishing a virtuous cycle where
PRnewswire
9.5
2025-07-28PRnewswire
Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results
  • Financial Performance Overview: Ridgetech, Inc. reported stable revenue of approximately $120 million for the fiscal year ending March 31, 2025, despite a 3.2% decrease from the previous year. The company achieved a net income of $10.20 million, a significant turnaround from a net loss of $4.23 million in the prior year.

  • Strategic Business Transformation: The company underwent significant changes, including divesting its retail pharmacy business and acquiring Ridgeline and Allright to enhance its wholesale distribution capabilities in both online and offline markets, reflecting a strategic shift towards the wholesale pharmaceutical sector amidst increasing competition in China's healthcare industry.

Valuation Metrics

The current forward P/E ratio for Ridgetech Inc (RDGT.O) is 1.11, compared to its 5-year average forward P/E of 14.04. For a more detailed relative valuation and DCF analysis to assess Ridgetech Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
14.04
Current PE
1.11
Overvalued PE
43.41
Undervalued PE
-15.32

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

show me stocks under 50 cents billed
Intellectia · 178 candidates
Price: $0.00 - $0.50
Ticker
Name
Market Cap$
top bottom
LNKS logo
LNKS
Linkers Industries Ltd
319.75K
ITRM logo
ITRM
Iterum Therapeutics PLC
1.60M
RDGT logo
RDGT
Ridgetech Inc
596.11K
UCAR logo
UCAR
U Power Ltd
302.92K
HKIT logo
HKIT
Hitek Global Inc
1.68M
IOBT logo
IOBT
IO Biotech Inc
4.22M

Whales Holding RDGT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ridgetech Inc (RDGT) stock price today?

The current price of RDGT is 0.0278 USD — it has decreased -15.34

What is Ridgetech Inc (RDGT)'s business?

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

What is the price predicton of RDGT Stock?

Wall Street analysts forecast RDGT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RDGT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ridgetech Inc (RDGT)'s revenue for the last quarter?

Ridgetech Inc revenue for the last quarter amounts to NaN USD, decreased

What is Ridgetech Inc (RDGT)'s earnings per share (EPS) for the last quarter?

Ridgetech Inc. EPS for the last quarter amounts to USD, decreased

How many employees does Ridgetech Inc (RDGT). have?

Ridgetech Inc (RDGT) has 61 emplpoyees as of April 02 2026.

What is Ridgetech Inc (RDGT) market cap?

Today RDGT has the market capitalization of 508.34K USD.